FAM
TBIO

Fred Alger Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Fred Alger Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,503
Closed -$275K – 572
2022
Q2 		$275K Sell
8,503
-174
-2% -$12K ﹤0.01% 418
2022
Q1 		$839K Sell
8,677
-47
-0.5% -$7.13K ﹤0.01% 401
2021
Q4 		$1.7M Sell
8,724
-307
-3% -$47.8K ﹤0.01% 368
2021
Q3 		$1.81M Buy
9,031
+177
+2% +$44.9K ﹤0.01% 352
2021
Q2 		$3.51M Buy
+8,854
New +$3.13M 0.01% 323

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return